Chemotherapy Medications in Sub-Saharan Africa: Availability, Pricing, Affordability, and Predictors of Quality
We found that medicines for cancer treatment are unaffordable without government subsidies. Moreover, poor-quality chemotherapy medicines are hard to detect without chemical testing. Government policies and supply chain practice changes are needed to improve the availability, affordability, and quality of chemotherapy medications in sub-Saharan Africa.
Authors
- Atalay Mulu Fentie (ORCID: https://orcid.org/0000-0001-6065-0695)
- Phelix Makoto Were
- Ayenew Ashenef (ORCID: https://orcid.org/0000-0003-2505-899X)
- Ekezie Matthew Okorigwe (ORCID: https://orcid.org/0000-0002-1967-4713)
- P Ndom
- Sonak D. Pastakia
- Maximilian J Wilfinger
- Jack Doohan
- Yauba Saidu
- Ibrahim Chikowe
- Marya Lieberman
- Jesse Opakas
- Colleen R. Higgins
- Benyam Muluneh
- Hanna Stanbuli Kumwenda
Institutions
- University of Notre Dame (US)
- University of North Carolina at Chapel Hill (US)
- Université de Yaoundé I (CM)
- Moi University (KE)
- American Association of Colleges of Pharmacy (US)
- Purdue University West Lafayette (US)
- Kamuzu Central Hospital (MW)
- Clinton Health Access Initiative (US)
- AMPATH (KE)
- Korea University (JP)
- Kamuzu University of Health Sciences (MW)
- Addis Ababa University (ET)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1200/go-25-00118
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00